A Director at Masimo Corp is Exercising Options

By Carrie Williams

Today it was reported that a Director at Masimo Corp (MASIResearch Report), Steven Barker, exercised options to buy 1,413 MASI shares at $137.95 a share, for a total transaction value of $194.9K.

Following Steven Barker’s last MASI Buy transaction on February 26, 2015, the stock climbed by 99.3%. In addition to Steven Barker, 3 other MASI executives reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

Based on Masimo Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $232 million and quarterly net profit of $49.32 million. In comparison, last year the company earned revenue of $213 million and had a net profit of $45.63 million. MASI’s market cap is $6.97B and the company has a P/E ratio of 36.88. Currently, Masimo Corp has an average volume of 719.2K.

Based on 4 analyst ratings, the analyst consensus is Strong Buy with an average price target of $159.33, reflecting a 23.4% upside. Three different firms, including Needham and Piper Jaffray, currently also have a Buy rating on the stock.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories.